Osaic Holdings
LXRX icon

Osaic Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History

Osaic Holdings’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390 Sell
163
-500
-75% -$974 ﹤0.01% 7698
2026
Q1 		$1.03K Buy
663
+21
+3% +$31 ﹤0.01% 7258
2025
Q4 		$738 Sell
642
-100
-13% -$137 ﹤0.01% 7350
2025
Q3 		$816 Hold
742
– – ﹤0.01% 7425
2025
Q2 		$697 Sell
742
-200
-21% -$130 ﹤0.01% 7277
2025
Q1 		$433 Buy
942
+200
+27% +$126 ﹤0.01% 7023
2024
Q4 		$549 Hold
742
– – ﹤0.01% 6999
2024
Q3 		$1.16K Hold
742
– – ﹤0.01% 6796
2024
Q2 		$1.25K Sell
742
-693
-48% -$1.24K ﹤0.01% 6752
2024
Q1 		$3.44K Buy
1,435
+41
+3% +$88 ﹤0.01% 6250
2023
Q4 		$2.13K Sell
1,394
-5,850
-81% -$6.96K ﹤0.01% 6522
2023
Q3 		$7.89K Buy
7,244
+876
+14% +$1.54K ﹤0.01% 6063
2023
Q2 		$14.6K Buy
6,368
+3,486
+121% +$9.25K ﹤0.01% 5754
2023
Q1 		$7K Sell
2,882
-392
-12% -$898 ﹤0.01% 6178
2022
Q4 		$6K Sell
3,274
-340
-9% -$724 ﹤0.01% 6204
2022
Q3 		$8K Buy
3,614
+1,023
+39% +$2.83K ﹤0.01% 6131
2022
Q2 		$4K Buy
2,591
+109
+4% +$208 ﹤0.01% 6604
2022
Q1 		$4K Sell
2,482
-77
-3% -$213 ﹤0.01% 6612
2021
Q4 		$10K Buy
2,559
+1,035
+68% +$5.03K ﹤0.01% 6246
2021
Q3 		$7K Buy
1,524
+200
+15% +$821 ﹤0.01% 6387
2021
Q2 		$6K Sell
1,324
-365
-22% -$1.76K ﹤0.01% 6296
2021
Q1 		$10K Sell
1,689
-101
-6% -$699 ﹤0.01% 5870
2020
Q4 		$5K Buy
1,790
+646
+56% +$1.23K ﹤0.01% 5778
2020
Q3 		$1K Sell
1,144
-1,476
-56% -$2.63K ﹤0.01% 6029
2020
Q2 		$5K Buy
2,620
+375
+17% +$735 ﹤0.01% 5478
2020
Q1 		$4K Buy
+2,245
New +$6.68K ﹤0.01% 5445

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Osaic Holdings's LXRX Position: Q2 2026 in Review

Osaic Holdings reduced its Lexicon Pharmaceuticals (LXRX) stake by 75% in Q2 2026, selling an estimated $974 and leaving 163 shares worth $390. The position accounts for ﹤0.01% of the portfolio, ranked #7698.

Osaic Holdings first reported a position in LXRX in Q1 2020 and has held it in 26 quarters since. The position peaked at $14.6K in Q2 2023. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Osaic Holdings held 163 shares of Lexicon Pharmaceuticals worth $390 as of Q2 2026.
  • Osaic Holdings sold 500 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $974.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7698 holding.
  • Osaic Holdings first reported a position in Lexicon Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Lexicon Pharmaceuticals position peaked at $14.6K in Q2 2023.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.